Online Database of Chemicals from Around the World
Search |  Submit |  中文
Home >> Chemical Listing >> T >> 4-[4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]morpholine

4-[4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]morpholine
[CAS# 568577-88-8]

List of Suppliers
Boron Molecular Inc. USA Inquire  
+1 (919) 981-4441
sales@boronmolecular-usa.com
Chemical manufacturer since 2001
chemBlink standard supplier since 2009
BOC Sciences USA Inquire  
+1 (631) 485-4226
info@bocsci.com
Chemical manufacturer
chemBlink standard supplier since 2010
AK Scientific, Inc USA Inquire  
+1 (510) 429-8835
sales@aksci.com
Chemical manufacturer
Complete supplier list of 4-[4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]morpholine
Identification
Name 4-[4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]morpholine
Molecular Structure CAS # 568577-88-8, 4-[4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]morpholine
Molecular Formula C16H24BNO3
Molecular Weight 289.18
CAS Registry Number 568577-88-8
EC Number 675-072-5
Properties
Density 1.09±0.1 g/cm3 (20 ºC 760 Torr), Calc.*
Melting point 98.6-99.0 ºC**
* Calculated using Advanced Chemistry Development (ACD/Labs) Software V11.02 (©1994-2013 ACD/Labs)
** Yamamoto, Tetsuya; Organic Letters 2011, V13(21), P5766-5769.
Safety Data
Hazard Symbols symbol   Xn    Details
Risk Codes R22;R36/37/38    Details
Safety Description S26;S36/39    Details
Hazard Classification
up    Details
HazardClassCategory CodeHazard Statement
Acute toxicityAcute Tox.4H302
Skin irritationSkin Irrit.2H315
Eye irritationEye Irrit.2H319
Specific target organ toxicity - single exposureSTOT SE3H335
Acute toxicityAcute Tox.4H312
Acute toxicityAcute Tox.4H332
Eye irritationEye Irrit.2AH319
SDS Available
Market Analysis Reports
List of Reports Available for 4-[4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]morpholine
Related Products
2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenol  [4-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)phenyl]carbamic acid benzyl ester  9-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)carbazole  9-[4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-9H-carbazole  9-[2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-9H-carbazole  [1-[4-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)phenyl]cyclobutyl]carbamic acid tert-butyl ester  2-[4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-imidazole  (2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanamine  [4-(Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methanol  4-[[2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl]-1-piperazinecarboxylic acid 1,1-dimethylethyl ester  9-[3-[4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]phenyl]carbazole  (2E)-3-[4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-2-propenoic acid  4-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pyridine  2-[2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]pyridine  3-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pyridine  8-[4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]quinoline  5-[4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-2H-tetrazole  (E)-3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-2-propen-1-ol  N-[3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)propyl]carbamic acid 1,1-dimethylethyl ester  4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole-1-acetic acid